SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab
- 31 March 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Medical Oncology
- Vol. 34 (5), 75
- https://doi.org/10.1007/s12032-017-0938-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated CardiotoxicityJournal of Clinical Oncology, 2017
- Radiological assessment of breast density by visual classification (BI–RADS) compared to automated volumetric digital software (Quantra): implications for clinical practiceLa radiologia medica, 2014
- Managing Cardiotoxicity of ChemotherapyCurrent Treatment Options in Cardiovascular Medicine, 2013
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trialsThe Lancet, 2012
- Adjuvant Trastuzumab in HER2-Positive Breast CancerThe New England Journal of Medicine, 2011
- The Utility of Cardiac Biomarkers, Tissue Velocity and Strain Imaging, and Cardiac Magnetic Resonance Imaging in Predicting Early Left Ventricular Dysfunction in Patients With Human Epidermal Growth Factor Receptor II–Positive Breast Cancer Treated With Adjuvant Trastuzumab TherapyJournal of the American College of Cardiology, 2011
- Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic studyHeart, 2010
- Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast CancerThe New England Journal of Medicine, 2005
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerThe New England Journal of Medicine, 2005
- Cardiac Dysfunction in the Trastuzumab Clinical Trials ExperienceJournal of Clinical Oncology, 2002